David Johnson
2019 - Global Blood Therapeutics
In 2019, David Johnson earned a total compensation of $3.2M as Chief Commercial Officer at Global Blood Therapeutics, a 27% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $250,000 |
|---|---|
| Option Awards | $1,267,784 |
| Salary | $453,125 |
| Stock Awards | $1,211,000 |
| Other | $5,000 |
| Total | $3,186,909 |
Johnson received $1.3M in option awards, accounting for 40% of the total pay in 2019.
Johnson also received $250K in non-equity incentive plan, $453.1K in salary, $1.2M in stock awards and $5K in other compensation.
Rankings
In 2019, David Johnson's compensation ranked 3,830th out of 13,971 executives tracked by ExecPay. In other words, Johnson earned more than 72.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,830 out of 13,971 | 73rd |
Division Manufacturing | 1,384 out of 5,695 | 76th |
Major group Chemicals And Allied Products | 486 out of 2,194 | 78th |
Industry group Drugs | 410 out of 1,880 | 78th |
Industry Pharmaceutical Preparations | 311 out of 1,392 | 78th |
Source: SEC filing on April 28, 2021.
Johnson's colleagues
We found four more compensation records of executives who worked with David Johnson at Global Blood Therapeutics in 2019.